Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Takes COI Into Its Own Hands

Harvard Medical School is instituting tough new conflict-of-interest rules for its faculty, the New York Times and The Boston Globe report. The new policy, which will take effect on January 1, prohibits Harvard staff from taking industry money to speak for pharmaceutical or medical device makers, and from accepting gifts, travel or meals. The university has also capped the amount of money a faculty member can receive from a company whose product or invention he or she is studying at $10,000 — the previous limit was $20,000, the Times reports.

NPR's Shots blog says there are still some things Harvard researchers can take money for. They can still take industry money for speeches they make about drugs or devices, but only if those speeches are crafted independently, not a company-written promo. The doctors can also take money for consulting (though anything over $5,000 has to be publicly reported), and can still take industry money to pay for continuing education classes (though there are new restrictions).

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.